These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 26027572)

  • 1. Lipid-Based Nanocarriers for RNA Delivery.
    Xue HY; Guo P; Wen WC; Wong HL
    Curr Pharm Des; 2015; 21(22):3140-7. PubMed ID: 26027572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Budding Alliance of Nanotechnology in RNA Interference Therapeutics.
    Kumawat A; Dapse P; Kumar N; Mishra DK; Maheshwari R; Bhattacharya P; Tekade RK
    Curr Pharm Des; 2018; 24(23):2632-2643. PubMed ID: 30084328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
    Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
    Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in siRNA delivery.
    Sarisozen C; Salzano G; Torchilin VP
    Biomol Concepts; 2015 Dec; 6(5-6):321-41. PubMed ID: 26609865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonviral pulmonary delivery of siRNA.
    Merkel OM; Kissel T
    Acc Chem Res; 2012 Jul; 45(7):961-70. PubMed ID: 21905687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A combinatorial library of lipid-like materials for delivery of RNAi therapeutics.
    Akinc A; Zumbuehl A; Goldberg M; Leshchiner ES; Busini V; Hossain N; Bacallado SA; Nguyen DN; Fuller J; Alvarez R; Borodovsky A; Borland T; Constien R; de Fougerolles A; Dorkin JR; Narayanannair Jayaprakash K; Jayaraman M; John M; Koteliansky V; Manoharan M; Nechev L; Qin J; Racie T; Raitcheva D; Rajeev KG; Sah DW; Soutschek J; Toudjarska I; Vornlocher HP; Zimmermann TS; Langer R; Anderson DG
    Nat Biotechnol; 2008 May; 26(5):561-9. PubMed ID: 18438401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bridging small interfering RNA with giant therapeutic outcomes using nanometric liposomes.
    Singh Y; Tomar S; Khan S; Meher JG; Pawar VK; Raval K; Sharma K; Singh PK; Chaurasia M; Surendar Reddy B; Chourasia MK
    J Control Release; 2015 Dec; 220(Pt A):368-387. PubMed ID: 26528900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanostructured Hyaluronic Acid-based Materials for the Delivery of siRNA.
    Shah K; Chawla S; Gadeval A; Reddy G; Maheshwari R; Kalia K; Tekade RK
    Curr Pharm Des; 2018; 24(23):2678-2691. PubMed ID: 30084325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanosystems based on siRNA silencing HuR expression counteract diabetic retinopathy in rat.
    Amadio M; Pascale A; Cupri S; Pignatello R; Osera C; D Agata V; D Amico AG; Leggio GM; Ruozi B; Govoni S; Drago F; Bucolo C
    Pharmacol Res; 2016 Sep; 111():713-720. PubMed ID: 27475885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential enhancement and targeting strategies of polymeric and lipid-based nanocarriers in dermal drug delivery.
    Kahraman E; Güngör S; Özsoy Y
    Ther Deliv; 2017 Nov; 8(11):967-985. PubMed ID: 29061106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond liposomes: Recent advances on lipid based nanostructures for poorly soluble/poorly permeable drug delivery.
    Teixeira MC; Carbone C; Souto EB
    Prog Lipid Res; 2017 Oct; 68():1-11. PubMed ID: 28778472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle Delivery Systems for DNA/RNA and their Potential Applications in Nanomedicine.
    Shen H; Huang X; Min J; Le S; Wang Q; Wang X; Dogan AA; Liu X; Zhang P; Draz MS; Xiao J
    Curr Top Med Chem; 2019; 19(27):2507-2523. PubMed ID: 31775591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved multidetector asymmetrical-flow field-flow fractionation method for particle sizing and concentration measurements of lipid-based nanocarriers for RNA delivery.
    Mildner R; Hak S; Parot J; Hyldbakk A; Borgos SE; Some D; Johann C; Caputo F
    Eur J Pharm Biopharm; 2021 Jun; 163():252-265. PubMed ID: 33745980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of Carbon Nanomaterials in Gene Delivery for Endogenous RNA Interference In Vitro and In Vivo.
    Li L; Wen Y; Xu Q; Xu L; Liu D; Liu G; Huang Q
    Curr Pharm Des; 2015; 21(22):3191-8. PubMed ID: 26027567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifunctional pH-Sensitive Amino Lipids for siRNA Delivery.
    Gujrati M; Vaidya A; Lu ZR
    Bioconjug Chem; 2016 Jan; 27(1):19-35. PubMed ID: 26629982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J; Farzan M
    World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.
    Namiki Y; Fuchigami T; Tada N; Kawamura R; Matsunuma S; Kitamoto Y; Nakagawa M
    Acc Chem Res; 2011 Oct; 44(10):1080-93. PubMed ID: 21786832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid nanocarriers (LNC) and their applications in ocular drug delivery.
    Puglia C; Offerta A; Carbone C; Bonina F; Pignatello R; Puglisi G
    Curr Med Chem; 2015; 22(13):1589-602. PubMed ID: 25666802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNAi-based therapeutics and tumor targeted delivery in cancer.
    Kara G; Calin GA; Ozpolat B
    Adv Drug Deliv Rev; 2022 Mar; 182():114113. PubMed ID: 35063535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecularly engineered siRNA conjugates for tumor-targeted RNAi therapy.
    Lee JW; Choi J; Choi Y; Kim K; Yang Y; Kim SH; Yoon HY; Kwon IC
    J Control Release; 2022 Nov; 351():713-726. PubMed ID: 36152808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.